Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Jan;84(1):185–191.

Influence of some agents that affect 5-hydroxytryptamine metabolism and receptors on nitrazepam-induced sleep in mice.

C Wambebe
PMCID: PMC1987228  PMID: 3156646

Abstract

The effects of 5-hydroxytryptophan (5-HTP), citalopram, p-chlorophenylalanine (PCPA), cyproheptadine, lysergic acid diethylamide (LSD-25), metitepine and NSD 1034 on nitrazepam-induced sleep were investigated in mice. Nitrazepam (1.6-25.6 mg kg-1, i.p.) induced a dose-dependent sedative-hypnotic effect. 5-HTP (8-128 mg kg-1 i.m.) did not induce behavioural sleep but sedated mice and significantly potentiated nitrazepam-induced sleep. Similarly, 5-HTP (4-32 mg kg-1, i.m.) increased pentobarbitone sleeping time. Citalopram (2.5-10 mg kg-1, i.p.) significantly potentiated nitrazepam sleep. PCPA (300-400 mg kg-1, i.p.) completely abolished nitrazepam sleep; 5-HTP (32 mg kg-1, i.m.) reversed this effect. NSD 1034 (75-150 mg kg-1, i.p.) antagonized the potentiating effect of 5-HTP (32 mg kg-1, i.m.) on nitrazepam sleep. Cyproheptadine (5-10 mg kg-1, i.p.) and LSD-25 (2.5-10 micrograms kg-1, i.p.) partially antagonized nitrazepam sleep. Similarly, 5-HTP-induced potentiation of nitrazepam sleep was antagonized by cyproheptadine and LSD-25. Metitepine (4-8 mg kg-1, i.p.) induced behavioural sleep and significantly potentiated nitrazepam sleep. Ro15-1788 (10 mg kg-1, i.p.) effectively antagonized nitrazepam-induced sleep. These results indicate that enhancement of central 5-HT neurotransmission may underlie nitrazepam-induced sleep in mice.

Full text

PDF
190

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOGDANSKI D. F., WEISSBACH H., UDENFRIEND Pharmacological studies with the serotonin precursor, 5-hydroxytryptophan. J Pharmacol Exp Ther. 1958 Feb;122(2):182–194. [PubMed] [Google Scholar]
  2. Barraclough B. M. Are there safer hypnotics than barbiturates? Lancet. 1974 Jan 12;1(7846):57–58. doi: 10.1016/s0140-6736(74)93055-4. [DOI] [PubMed] [Google Scholar]
  3. Chadwick D., Gorrod J. W., Jenner P., Marsden C. D., Reynolds E. H. Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugs. Br J Pharmacol. 1978 Jan;62(1):115–124. doi: 10.1111/j.1476-5381.1978.tb07013.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dray A., Davies J., Oakley N. R., Tongroach P., Vellucci S. The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations. Brain Res. 1978 Aug 11;151(3):431–442. doi: 10.1016/0006-8993(78)91077-6. [DOI] [PubMed] [Google Scholar]
  5. Haefely W., Kulcsár A., Möhler H., Pieri L., Polc P., Schaffner R. Possible involvement of GABA in the central actions of benzodiazepines. Adv Biochem Psychopharmacol. 1975;(14):131–151. [PubMed] [Google Scholar]
  6. Hyttel J. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology (Berl) 1977 Mar 16;51(3):225–233. doi: 10.1007/BF00431629. [DOI] [PubMed] [Google Scholar]
  7. Jacoby J. H., Poulakos J. J., Bryce G. F. On the central anti-serotoninergic actions of cyproheptadine and methysergide. Neuropharmacology. 1978 Apr-May;17(4-5):299–306. doi: 10.1016/0028-3908(78)90115-6. [DOI] [PubMed] [Google Scholar]
  8. Jouvet M. Biogenic amines and the states of sleep. Science. 1969 Jan 3;163(3862):32–41. doi: 10.1126/science.163.3862.32. [DOI] [PubMed] [Google Scholar]
  9. Koella W. P., Feldstein A., Czicman J. S. The effect of para-chlorophenylalanine on the sleep of cats. Electroencephalogr Clin Neurophysiol. 1968 Nov;25(5):481–490. doi: 10.1016/0013-4694(68)90158-2. [DOI] [PubMed] [Google Scholar]
  10. Koella W. P. Serotonin and sleep. Exp Med Surg. 1969;27(1-2):157–168. [PubMed] [Google Scholar]
  11. Monachon M. A., Burkard W. P., Jalfre M., Haefely W. Blockade of central 5-hydroxytryptamine receptors by methiothepin. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(2):192–197. doi: 10.1007/BF00501854. [DOI] [PubMed] [Google Scholar]
  12. Mouret J., Bobillier P., Jouvet M. Insomnia following parachlorophenylalanine in the rat. Eur J Pharmacol. 1968 Dec;5(1):17–22. doi: 10.1016/0014-2999(68)90151-9. [DOI] [PubMed] [Google Scholar]
  13. Osuide G., Wambebe C. Antagonism of pentobarbitone sleep by dopamine, levodopa and apomorphine in chicks. Clin Exp Pharmacol Physiol. 1980 May-Jun;7(3):237–248. doi: 10.1111/j.1440-1681.1980.tb00068.x. [DOI] [PubMed] [Google Scholar]
  14. Pratt J., Jenner P., Reynolds E. H., Marsden C. D. Clonazepam induces decreased serotoninergic activity in the mouse brain. Neuropharmacology. 1979 Oct;18(10):791–799. doi: 10.1016/0028-3908(79)90024-8. [DOI] [PubMed] [Google Scholar]
  15. Sanghvi I., Gershon S. Similarities between behavioral and pharmacological actions of yohimbine and 5-hydroxytryptophan in the conscious dog. Eur J Pharmacol. 1970 Jul 15;11(2):125–129. doi: 10.1016/0014-2999(70)90041-5. [DOI] [PubMed] [Google Scholar]
  16. Stein L., Wise C. D., Belluzzi J. D. Effects of benzodiazepines on central serotonergic mechanisms. Adv Biochem Psychopharmacol. 1975;(14):29–44. [PubMed] [Google Scholar]
  17. Tanner T. Circling behaviour in the rat following unilateral injections of p-chlorophenylalanine and ethanolamine-O-sulphate into the substantia nigra. J Pharm Pharmacol. 1978 Mar;30(3):158–161. doi: 10.1111/j.2042-7158.1978.tb13188.x. [DOI] [PubMed] [Google Scholar]
  18. Valzelli L., Garattini S. Biogenic amines in discrete brain areas after treatment with monoamineoxidase inhibitors. J Neurochem. 1968 Mar;15(3):259–261. doi: 10.1111/j.1471-4159.1968.tb06205.x. [DOI] [PubMed] [Google Scholar]
  19. Wambebe C. Influence of some GABAergic agents on nitrazepam-induced sleep in the domestic fowl (Gallus domesticus). Jpn J Pharmacol. 1983 Dec;33(6):1111–1118. doi: 10.1254/jjp.33.1111. [DOI] [PubMed] [Google Scholar]
  20. Wambebe C. Influence of some serotoninergic agents on nitrazepam-induced sleep in the domestic fowl (Gallus domesticus). Gen Pharmacol. 1983;14(5):491–495. doi: 10.1016/0306-3623(83)90108-8. [DOI] [PubMed] [Google Scholar]
  21. Wambebe C., Osuide G. Influence of FLA-63 on pentobarbitone sleep in chicks and rats. Clin Exp Pharmacol Physiol. 1983 Sep-Oct;10(5):555–566. doi: 10.1111/j.1440-1681.1983.tb00224.x. [DOI] [PubMed] [Google Scholar]
  22. Weitzman E. D., Rapport M. M., McGregor P., Jacoby J. Sleep patterns of the monkey and brain serotonin concentration: effect of p-chlorophenylalanine. Science. 1968 Jun 21;160(3834):1361–1363. doi: 10.1126/science.160.3834.1361. [DOI] [PubMed] [Google Scholar]
  23. Wise C. D., Berger B. D., Stein L. Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science. 1972 Jul 14;177(4044):180–183. doi: 10.1126/science.177.4044.180. [DOI] [PubMed] [Google Scholar]
  24. Zbinden G., Randall L. O. Pharmacology of benzodiazepines: laboratory and clinical correlations. Adv Pharmacol. 1967;5:213–291. doi: 10.1016/s1054-3589(08)60658-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES